
Academic Journal
Q1Drug Metabolism Reviews
About Drug Metabolism Reviews
Drug Metabolism Reviews is a scholarly journal published by Taylor and Francis Ltd.. SCImago 2025 lists it in Q1, with an SJR of 0.93 and H-index of 117.
Coverage: 1972, 1974-2026. Research categories: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2).
Source-backed journal facts
Topics in published research
Pharmacogenetics and Drug Metabolism; Drug Transport and Resistance Mechanisms; Drug-Induced Hepatotoxicity and Protection; Computational Drug Discovery Methods; Carcinogens and Genotoxicity Assessment; Eicosanoids and Hypertension Pharmacology.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Reprogramming of hepatic drug metabolism following early-life xenobiotic exposure: insights from nuclear receptor pathways
Yanjiao Qiu, Xiaoyang Hou, Jing Guo, Qiangyu Zhang et al.
2026-09-16 · DOI: 10.1080/03602532.2026.2730198Metabolic pharmacology of anthelmintic drugs targeting mitochondrial fumarate reductase in neurocysticercosis
Marina Clare Vinaud, José Clecildo Barreto Bezerra
2026-09-03 · DOI: 10.1080/03602532.2026.2724981Metabolism-driven hepatotoxicity of 5-fluorouracil: molecular mechanisms and future therapeutic directions
Muthusethupathi Sharmila, Devaraj Ezhilarasan
2026-09-02 · DOI: 10.1080/03602532.2026.2724971SAR and mechanistic pathways of oxadiazole derivatives: targeting enzymes for antidiabetic therapy
Anuradha Mehra, Amit Mittal
2026-08-24 · DOI: 10.1080/03602532.2026.2721999Humanized mouse models for drug metabolism and drug transport: a systematic review
Ibrahim Z. Hassan, Wihan Pheiffer, Rose Hayeshi
2026-07-09 · DOI: 10.1080/03602532.2026.2697751Bioactivation and reactivity research advances – 2025 year in review
Joyce Liu, Upendra A. Argikar, Pietro Brunetti, Maria Chatzopoulou et al.
2026-07-03 · DOI: 10.1080/03602532.2026.2705851Drug transporters in drug disposition – highlights from the year 2025
Philip Sandoval, Pallabi Mitra, Masanori Nakakariya, Diane Ramsden et al.
2026-07-03 · DOI: 10.1080/03602532.2026.2690529Herbal supplements and anti-tuberculosis therapy: unlocking hidden interactions for better multidrug-resistant tuberculosis management
Siva Bhukya, Ravi Adinarayan Somabattini, Neelanjan Chowdhury, Sathi Sarkar et al.
2026-07-03 · DOI: 10.1080/03602532.2026.2688186Identification and characterization of a novel aldehyde metabolite of WIN18,446 and associated WIN18,446-ALDH1A2 protein adducts using mass spectrometry
Alex Zelter, Guo Zhong, Michal Maes, Michael R. Hoopmann et al.
2026-06-08 · DOI: 10.1080/03602532.2026.2670538Biotransformation research advances—2025 year in review
Lionel Cheruzel, Upendra A. Argikar, Pietro Brunetti, Maria Chatzopoulou et al.
2026-07-03 · DOI: 10.1080/03602532.2026.2666155Pharmacomicrobiomics in precision pharmacotherapy: bidirectional microbial-drug interactions as a key determinant of therapeutic response
Serap Yalçın Azarkan, Habibe Sema Arslan Ünal, Sevinç Akçay
2026-07-03 · DOI: 10.1080/03602532.2026.2671428Population pharmacokinetics of levofloxacin: a systematic review
Yifan Ding, Xianghai Zeng, Jing Zou, Yuxue Zhou et al.
2026-07-03 · DOI: 10.1080/03602532.2026.2670536Metabolism of new drug modalities research advances – 2025 year in review
Bin Ma, Lionel Cheruzel, Sungjoon Cho, Simon Hauri et al.
2026-07-03 · DOI: 10.1080/03602532.2026.2663169Extracellular vesicles as xenobiotic-metabolizing enzyme carriers: a new paradigm for brain drug metabolism
Veena V Tom, Ann Mary Jose, Athira Sasidharan, Yogish Somayaji et al.
2026-07-03 · DOI: 10.1080/03602532.2026.2666163Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy
Mostafa K. Abd El-Aziz, Ali H. Shalaby, Sara R. El-Mahrouk, Ayman O. S. El-Kadi et al.
2026-07-03 · DOI: 10.1080/03602532.2026.2667929Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review
Tahir Saleem, Muhammad Fawad Rasool, Hamid Saeed, Faleh Alqahtani et al.
2026-07-03 · DOI: 10.1080/03602532.2026.2668704Simplified approaches to kinetic isotope effects in cytochrome P450-catalyzed reactions and relevance to deuterated drugs
F. Peter Guengerich
2026-04-28 · DOI: 10.1080/03602532.2026.2657290A review on analytical perspectives for cyclophosphamide, its metabolites, and impurities
Harshal Ahirrao, Hemant Kumar Tatapudi, Kishore Raju Vatsavai
2026-04-03 · DOI: 10.1080/03602532.2026.2649791Redox enzyme networks shaping cancer drug metabolism and therapeutic resistance
Başak Gökçe, Şeyma Rana Karakaş
2026-04-03 · DOI: 10.1080/03602532.2026.2645795A critical review of analytical tools for the detection of spironolactone and its metabolites
Hemn A. H. Barzani, Rebaz Anwar Omer, Khalamala Ibrahim Salih Barzani, Amjad Mahmood Qadir et al.
2026-04-03 · DOI: 10.1080/03602532.2026.2641226Reviews
Community Reviews
Version History
October 4, 2026 at 9:01 pm
October 2, 2026